ACHE and Alzheimer disease: Recent researches showed that AChE inhibitors not only alleviate the cognitive defect of AD patients by elevating acetylcholine (ACh) levels, but also act as disease modifying agents by preventing the early step of AD, the assembly of β-amyloid peptide (Aβ) into amyloid plaque23,24.